skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

Products

もっと見る

もっと見る

99+ Total results for product and free and sample content found

ターゲット市場の実像をつかむ

Understand Market Access Trends in the US, Europe and Emerging Markets

14 Nov 2022

This essential whitepaper looks at how increased drug spending and a rising desire for expenditure controls are influencing access dynamics across key markets. It is available to you now, for free.

Topic Drug Development Landscape Approvals Drug Review

Biomedtracker: 開発中医薬品をFDA承認確率で評価, ターゲット市場の実像を...

2020 Deal-Making Roundup

21 Sep 2021

2020 Deal-Making Roundup

Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

Topic Drug Review Coronavirus

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetr...

Q3 2021 Outlook Report

27 Aug 2021

Q3 2021 Outlook Report

What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.

Topic Drug Review

ターゲット市場の実像をつかむ

Top 10 Best-Selling Drugs of 2020

02 Jul 2021

Top 10 Best-Selling Drugs of 2020

One hundred billion dollars. That is the combined revenue of the top 10 pharmaceuticals in 2020, marking the first year in which this threshold has been crossed.

Topic Drug Review Drug Pricing

Generics Bulletin: ジェネリック&バイオシミラーニュース

Glenmark Debuts Favipiravir For COVID-19 In India

27 Nov 2020

covid-research

Glenmark has received the go-ahead in India for and launched its low-priced favipiravir product for mild to moderate COVID-19 under an accelerated approval process.

Topic Coronavirus Drug Review

世界の薬事規制動向&情報を配信

What Did US FDA Do Wrong In Its Review Of Aducanumab AdCom Members Have A List

By Brenda Sandburg 17 Nov 2020

FDA Advisory Committee

Committee members rebuked FDA for its positive review of Biogen’s Alzheimer’s disease drug, objecting to its ‘terrifically one-sided’ analysis of data, the short shrift given the contrary conclusions of its own statistician, and its interpretation of a dosing study to support the sole positive Phase III study.

Topic advisory committees Drug Review FDA

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。


新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。

お問合せの際はフォームまたは下記メールアドレスをご利用頂くか、営業担当者の携帯電話までご連絡下さいますようご協力をお願い申し上げます。

インフォーマインテリジェンス合同会社
サイトライン(旧ファーマインテリジェンス)
Eメール:
inquiry.jp@informa.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。